STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).

NHIF Benchmarking Program

Be part of NHIF’s benchmarking program to collect industry-wide, standardized data to establish a national reference point for performance and clinical metrics.

 

COVID-19 HOME INFUSION THERAPY PROGRAM (C-HIT)

Learn more about COVID-19 monoclonal antibodies and how to particpate in NHIA’s C-HIT program.

ADVOCACY INITIATIVES

Compete in NHIA’s Advocacy Olympics & Podium Challenge.

Latest News

October 15, 2021
NHIF Fellow Program
The application process for the 2022 class of NHIA Fellows is now open. Sponsored by IMS, the Fellow program seeks to advance the home and specialty infusion profession through practice, excellence, and leadership.

Application Deadline: Nov. 7, 2021

October 5, 2021
Transitional Benefit Did Not Boost DMEPOS Utilization In 2019
New publicly available data from the Centers for Medicare and Medicaid Services for CY 2019 shows that beneficiary utilization of the Part B DMEPOS home infusion benefit continued to decline despite the availability of the additional payment for nursing services under the transitional benefit.

September 14, 2021
NHIA Submits Comments on Proposed 2022 Physician Fee Schedule
NHIA submitted comments to the Centers for Medicare and Medicaid Services (CMS) on a proposed rule that outlined CY 2022 payment policies under the Physician Fee Schedule and other changes to Medicare Part B payment polices.

September 13, 2021
NHIA To Publish Scholarly Journal for Infusion Therapies
This new scholarly journal will feature independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.

September 8, 2021
NHIA and 20+ Organizations Sign Joint Letter To Congress To Support Home Infusion Legislation​
On September 8, a group of stakeholders, including home infusion providers, patient advocacy groups, professional societies, and industry suppliers, sent a letter to leaders in the House of Representatives and the Senate encouraging them to pass the Preserving Patient Access to Home Infusion Act (S 2652; H.R. 5067).

August 27, 2021
NHIA Comments On Medicare Home Health Proposed Rule
NHIA has submitted comments to CMS on the CY 2022 Home Health Rule which outlines proposed coverage and policy changes for home infusion and other post-acute services. 

August 23, 2021
NHIA Applauds House Introduction of Bipartisan
Home Infusion Legislation

A companion bill to S.2652, The Preserving Patient Access to Home Infusion Act (H.R. 5067) — introduced in the House by Reps. Terri Sewell (D-AL), Debbie Dingell (D-MI), Fred Upton (R-MI), and Vern Buchannan (R-FL) — would ensure patients with serious viral and fungal infections, heart failure, immune diseases, cancer, and other conditions can receive the intravenous (IV) medications they need while at home.

August 5, 2021
Bipartisan Legislation Would Maintain Home Infusion Access Among Medicare Beneficiaries
The Preserving Patient Access to Home Infusion Act — introduced by Sen. Mark Warner (D-VA) and Sen. Tim Scott (R-SC) — would ensure patients with serious viral and fungal infections, heart failure, immune diseases, cancer, and other conditions can receive the intravenous (IV) medications they need while at home.

We Need Your Support

NHIA is dedicating extra resources to pursue legislation to allow home infusion providers to serve Medicare beneficiaries during the public health emergency related to COVID-19.